Intelligence Mission: Berg Finds a Buyer
Investor group BPGbio acquires company’s AI platform, built with $400M in investment, its drug and diagnostic pipelines
By Alex Philippidis –
February 8, 2023
After investing around $400 million to develop its artificial intelligence (AI)-based platform and the company formed to commercialize it, Berg has placed its drug and diagnostic pipelines in the hands of an investor group that has completed its purchase of the 14-year-old company.